1. Home
  2. ABP vs KPLT Comparison

ABP vs KPLT Comparison

Compare ABP & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABP
  • KPLT
  • Stock Information
  • Founded
  • ABP 2004
  • KPLT 2012
  • Country
  • ABP United States
  • KPLT United States
  • Employees
  • ABP N/A
  • KPLT N/A
  • Industry
  • ABP Biotechnology: Pharmaceutical Preparations
  • KPLT Diversified Commercial Services
  • Sector
  • ABP Health Care
  • KPLT Consumer Discretionary
  • Exchange
  • ABP Nasdaq
  • KPLT Nasdaq
  • Market Cap
  • ABP 17.2M
  • KPLT 97.4M
  • IPO Year
  • ABP N/A
  • KPLT N/A
  • Fundamental
  • Price
  • ABP $0.18
  • KPLT $19.42
  • Analyst Decision
  • ABP Strong Buy
  • KPLT Hold
  • Analyst Count
  • ABP 1
  • KPLT 1
  • Target Price
  • ABP $4.00
  • KPLT $10.00
  • AVG Volume (30 Days)
  • ABP 3.2M
  • KPLT 89.7K
  • Earning Date
  • ABP 08-13-2025
  • KPLT 11-05-2025
  • Dividend Yield
  • ABP N/A
  • KPLT N/A
  • EPS Growth
  • ABP N/A
  • KPLT N/A
  • EPS
  • ABP N/A
  • KPLT N/A
  • Revenue
  • ABP $183,000.00
  • KPLT $267,101,999.00
  • Revenue This Year
  • ABP N/A
  • KPLT $22.88
  • Revenue Next Year
  • ABP N/A
  • KPLT $10.98
  • P/E Ratio
  • ABP N/A
  • KPLT N/A
  • Revenue Growth
  • ABP 154.17
  • KPLT 13.04
  • 52 Week Low
  • ABP $0.15
  • KPLT $5.08
  • 52 Week High
  • ABP $11.19
  • KPLT $24.34
  • Technical
  • Relative Strength Index (RSI)
  • ABP 35.07
  • KPLT 60.20
  • Support Level
  • ABP $0.16
  • KPLT $13.25
  • Resistance Level
  • ABP $0.26
  • KPLT $24.34
  • Average True Range (ATR)
  • ABP 0.02
  • KPLT 2.19
  • MACD
  • ABP -0.01
  • KPLT 0.19
  • Stochastic Oscillator
  • ABP 19.90
  • KPLT 55.64

About ABP Abpro Holdings Inc Common Stock

Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

About KPLT Katapult Holdings Inc.

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

Share on Social Networks: